WSMI director general
This article was originally published in The Tan Sheet
Executive Summary
World Self-Medication Industry names David Webber, PhD, to post of director general effective Dec. 1. Webber will replace Jerome Reinstein, PhD, who steps down after almost 12 years at the helm of the organization (1"The Tan Sheet" Oct. 8, 2001, In Brief). Webber, currently director of economic policy and fellow of the International Federation of Pharmaceutical Manufacturers Associations, brings 20 years of pharmaceutical industry experience. Separately, Albert Esteve named president of the Association of the European Self-Medication Industry for a two-year period effective July 1; he succeeds Alessandro Banchi, who headed AESGP from July 2000 through June of this year...
You may also be interested in...
WSMI
Director-General Jerome Reinstein, PhD, stepping down in November 2002 after almost 12 years at the post. He will continue as an industry consultant and permanent advisor to Latin American Self-Medication Industry. A director-general designate will be named in July, when World Self-Medication Industry relocates its offices from London to Geneva to better reflect group's status as a non-governmental organization in official relations with WHO
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.